Deepak L. Bhatt on Muck Rack

Deepak L. Bhatt

  • Director of Mount Sinai Heart, Mount Sinai Health System
New York
As seen in: Medium, National Institutes of Health, Arthritis & Rheumatology, Color Research & Application, Nature, Wiley, Wiley Online Library, Harvard Health Publishing, Memory Studies, ScienceDirect and
Dr. Deepak L. Bhatt is Director of Mount Sinai Heart and the Dr. Valentin Fuster Professor of Cardiovascular Medicine. Bio and COI: linkedin.com/in/dlbhattmd/.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Deepak L.

Contact Deepak L., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Comprehensive Strategies for Secondary Stroke Prevention

|
By Deepak L. Bhatt
| Consultant360
Primary care physicians play a pivotal role in preventing recurrent stroke. In this expert-led discussion on his Practical Updates in Primary Care Presentation, "Optimizing Outcomes: Key Updates in AHA Stroke Guidelines", Deepak L. Bhatt, MD, MPH outlines actionable strategies—ranging from dietary and lifestyle counseling to evidence-based pharmacotherapy—that clinicians can implement to reduce cardiovascular risk in patients with prior stroke or TIA.
Open in Who Shared Issue with article?

3 Trials That Will Change My Practice with Dr Deepak Bhatt

|
By Harriette Van Spall, Wayne Batchelor, Deepak L. Bhatt
| RadcliffeCardiology.com
Hello, I’m Dr. Deepak Bhatt, the Director of the Mount Sinai Fuster Heart Hospital at the Icahn School of Medicine at Mount Sinai in New York, and the Dr. Valentin Fuster Professor of Cardiovascular Medicine. There have been a lot of great trials this year at the American College of Cardiology. I’m just going to pick three to discuss. The first is actually an update of the SURPASS-CVOT trial. This was a more expanded analysis from SURPASS-CVOT, which compared tirzepatide versus dulaglutide.
Open in Who Shared Issue with article?

Heart Failure in 2026: Practical Therapy Lessons From ACC.26

|
By Felipe Martinez, Purvi Parwani, Deepak L. Bhatt
| The Radcliffe Cardiology Podcast
ACC.26 - In this expert interview filmed at ACC.26 in New Orleans, Prof. Felipe Martínez discusses how late-breaking heart failure data are reshaping contemporary pharmacological management. The conversation focuses on new spironolactone results, advanced hemodynamic strategies in HFpEF, and the expanding role of cardiometabolic therapies, including GLP‑1 receptor agonists, in optimising outcomes for complex heart failure patients.
Open in Who Shared Issue with article?
See all 448 licensed articles (464 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Deepak L.

Contact Deepak L., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified